- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03902015
"Nuance Hearing" for Attention Deficit Hyperactivity Disorder (ADHD)
April 2, 2019 updated by: Nuance Hearing
Technology Efficacy of "Nuance Hearing" Among Students Suffering From Attention Disorders- A Pilot Study
The aim of the current study is to examine whether the ability to avoid irrelevant auditory stimuli and focus hearing, enabled by the device developed by "Nuance Hearing", may help students with ADHD in classroom listening situations by significantly reducing background distractions.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Diagnosis of attention deficit hyperactivity disorder (ADHD) according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM IV)
- Have fulfilled the "Test of variables of attention"
- with normal hearing
Exclusion Criteria:
- Moderate to severe co-morbid psychiatric disorders
- Neurological chronic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Nuance Phone case
"Nuance Hearing" has developed a technology enabling focused hearing.
The Selective Noise Cancellation (SNC) technology consists of an advanced beam-forming algorithm that tones down the ambient sound by up to 15 decibels (dB) in order to focus on a primary audio source.
The device consists of a special phone case(for iPhone) containing microphone array.
Controlling the direction of focus is enabled through the use of a designated app.
The user can place the phone case on his/hers table and can choose the direction of preferred listening, without having to ask the talker to hold the device.
|
participants will receive a phone (iPhone) with the Nuance Phone case and a designated app required for the use of the device.
Participants will first undergo hearing test via the app, and afterwards (in case they are not excluded based on hearing status), will receive a introduction on how to use the app and the device.
Before starting the clinical trial, children will undergo three adjustments days in which they will practice using the device in school.
During this period the researchers will make sure that the participants are adapting to the use of the device, and in any case there is a problem, will be able to contact a representative of "Nuance Hearing" who will be available to support technical issues.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Listening inventory for education - revised (L.I.F.E - R) 1 week after baseline
Time Frame: 1 week after baseline
|
A self-assessment questionnaire for school aged children.
This version of the questionnaire was developed to assess effectiveness of sound enhancement devices in the school and other social activities.
The questionnaire is comprised of 10 items (for example - how well could you hear the words the teacher is saying when there is noise from the hallway") rated in a scale of 0 to 10, where 10 - always easy and 0- always difficult.
|
1 week after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Iris Manor, phd, Geha Mental Health Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 1, 2019
Primary Completion (ANTICIPATED)
January 1, 2020
Study Completion (ANTICIPATED)
February 1, 2020
Study Registration Dates
First Submitted
March 27, 2019
First Submitted That Met QC Criteria
April 2, 2019
First Posted (ACTUAL)
April 3, 2019
Study Record Updates
Last Update Posted (ACTUAL)
April 3, 2019
Last Update Submitted That Met QC Criteria
April 2, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NuanceADHD pilot
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
Clinical Trials on Nuance Phone case
-
University of California, San FranciscoTerminated
-
Joseph AdameCompletedTreatment for Obstructive Sleep ApneaUnited States
-
Ottawa Heart Institute Research CorporationCompletedCoronary Heart Disease | Valve Disease, HeartCanada
-
Planmed OyWithdrawnBreast CancerUnited States
-
McGill University Health Centre/Research Institute...GlaxoSmithKlineCompleted
-
AZ Sint-Jan AVCompletedAtrial Fibrillation | Atrial TachycardiaFrance, Belgium, Germany, United Kingdom
-
The University of Hong KongRecruitingCaregiver WellbeingHong Kong
-
TC Erciyes UniversityNot yet recruitingNursing Students | Artificial Intelligence (AI)Turkey (Türkiye)
-
TC Erciyes UniversityCompletedNursing Students | Artificial Intelligence (AI)Turkey
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); Oregon Health and Science University; University...Completed